Investing-News.Com
Information for Investors

AMYLIN PHARMA INC, (AMLN) Stock Ratings - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

AMYLIN PHARMA INC, (AMLN) Stock Rating Learn More

Our Overall Rating on Amylin Pharmaceuticals Inc,  AMLN is BUY
StockPickReport.Com research suggests AMLN's price will move significantly higher than the "open price" the day this rating was initiated.

This analysis is based on short-term stochastic and "relative strength" indicators.

Both stochastic and "relative strength" indicators point to a move up.

Investors, traders, and other market participants may find this a good opportunity to buy AMLN, "buy calls", or "sell puts".

This may also be an opportunity to raise targets and stop/losses to allow for potential gains.

Trading volume seems to be falling and AMLN's closing price moved up during the week before this rating was initiated.

Our BUY Rating on AMLN was issued on 03/25/08

AMYLIN PHARMA INC Technical Rating



Ratings Provided by Stock-Letter-Daily.Com

Rate Any Stock
(enter symbol and click)

Stock Rating Definitions

Stock Ratings Home

Sponsored Links:

Software Forces AMYLIN PHARMA INC Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in AMYLIN PHARMA INC buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on AMYLIN PHARMA INC. This software is specially designed to give precision entry and exit points on AMYLIN PHARMA INC, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When AMYLIN PHARMA INC Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even AMYLIN PHARMA INC, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: day trading education 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

Pharmaceuticals Industry (Zacks.com)

Icahn Takes on CEOs, Makes Big Moves in Biotech (Indie Research)

[$$] Biotech Mailbag: Recap on GenVec (at RealMoney by TheStreet.com)

Cash is King (Zacks.com)

DryShips, Amylin Pharmaceuticals and Eagle Bulk Shipping lead small-cap volume in pre-market (SmallCapInvestor.com)

Amylin Buyout Inevitable But Not Imminent (at Forbes.com)

Icahn's Next Biotech Adventure (at Motley Fool)

Novo Nordisk "Raises" Price On Treating Diabetes (at CNBC)

Will Carl Icahn Come to Amylin's Rescue? (at Seeking Alpha)

Icahn, Byetta Sales Boost Amylin (Update) (at TheStreet.com)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.